Efficacy News and Research

RSS
Celator presents new data on CPX-351 liposome injection at European Hematology Association congress

Celator presents new data on CPX-351 liposome injection at European Hematology Association congress

FDA grants Fast Track status for Genzyme's alemtuzumab development program for MS

FDA grants Fast Track status for Genzyme's alemtuzumab development program for MS

ConvaTec presents Vitala Continence Control Device Phase 2 data at 2010 WOCN/WCET joint conference

ConvaTec presents Vitala Continence Control Device Phase 2 data at 2010 WOCN/WCET joint conference

UCB announces availability of Vimpat oral solution formulation

UCB announces availability of Vimpat oral solution formulation

Upsher-Smith commences global USL255 Phase III clinical trial for management of epilepsy

Upsher-Smith commences global USL255 Phase III clinical trial for management of epilepsy

Telormedix initiates Phase I/II clinical study of TMX-101 for treating NMIBC

Telormedix initiates Phase I/II clinical study of TMX-101 for treating NMIBC

Biodel announces schedule for presentations at 70th Scientific Sessions of American Diabetes Association

Biodel announces schedule for presentations at 70th Scientific Sessions of American Diabetes Association

Abstract on Phase I/II DIGNITY trial of ThermoDox in RCW Breast Cancer accepted at ASTRO 2010

Abstract on Phase I/II DIGNITY trial of ThermoDox in RCW Breast Cancer accepted at ASTRO 2010

USPTO issues patent covering methods for enhancing RNA silencing activity of RNAi agents

USPTO issues patent covering methods for enhancing RNA silencing activity of RNAi agents

Nexavar does not meet primary endpoint in Phase 3 NExUS trial for advanced NSCLC

Nexavar does not meet primary endpoint in Phase 3 NExUS trial for advanced NSCLC

Chiasma successfully completes Phase I clinical study of Octreolin

Chiasma successfully completes Phase I clinical study of Octreolin

Data from Phase 1 study of FOLOTYN in patients with relapsed or refractory CTCL presented at EHA 2010

Data from Phase 1 study of FOLOTYN in patients with relapsed or refractory CTCL presented at EHA 2010

Phase II study results of riociguat for CTEPH and PAH published online

Phase II study results of riociguat for CTEPH and PAH published online

Phase 2b RESTORE-CLI clinical trial in patients with CLI reaches statistical significance

Phase 2b RESTORE-CLI clinical trial in patients with CLI reaches statistical significance

Researchers demonstrate efficacy of routine psychotherapeutic treatment for depression

Researchers demonstrate efficacy of routine psychotherapeutic treatment for depression

Cook Medical files for PMA of Zilver PTX Drug-Eluting Peripheral Stent with FDA

Cook Medical files for PMA of Zilver PTX Drug-Eluting Peripheral Stent with FDA

AVEO Pharmaceuticals presents tivozanib’s Phase 2 trial data at ASCO meeting

AVEO Pharmaceuticals presents tivozanib’s Phase 2 trial data at ASCO meeting

Abraxis BioScience presents phase 3 trial data on metastatic malignant melanoma

Abraxis BioScience presents phase 3 trial data on metastatic malignant melanoma

Repros receives FDA confirmation on lifting of full clinical hold on Proellex

Repros receives FDA confirmation on lifting of full clinical hold on Proellex

China-Biotics fourth-quarter revenues up 64.4% to $25.5 million

China-Biotics fourth-quarter revenues up 64.4% to $25.5 million

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.